文献速递腹部泌尿生殖USCTMR

对比增强超声LI-RADS 2017:与CT/MRI LI-RADS的比较

Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.
PubMed 文献 · Eur Radiol · 2020-08-15

该回顾性研究纳入239例患者273个结节,按CEUS LI-RADS 2017与CECT/MRI LI-RADS 2017分别分类并以组织病理为参考标准比较诊断效能。两种方法最终分类的一致性为一般(kappa=0.319),LR-5对HCC的阳性预测值相当,但CECT/MRI LR-M对非HCC恶性肿瘤的诊断效能优于CEUS LR-M。

要点

  • CEUS与CECT/MRI的LI-RADS最终分类一致性为一般(kappa=0.319)。
  • CEUS LR-5与CECT/MRI LR-5对HCC的阳性预测值相当。
  • CECT/MRI LR-M对非HCC恶性肿瘤的诊断效能优于CEUS LR-M。

核心结论

  • CEUS与CECT/MRI的LI-RADS分类一致性为一般(kappa=0.319,p<0.001)。
  • CEUS与CECT/MRI LI-RADS的LR-5对HCC的阳性预测值相当。
  • CECT/MRI LR-M对非HCC恶性肿瘤的诊断效能优于CEUS LR-M。

研究设计与样本

  • 回顾性研究,纳入239例患者共273个结节。
  • 每个结节分别按CEUS LI-RADS 2017版和CECT/MRI LI-RADS 2017版进行分类。
  • 参考标准为组织病理学诊断。
  • 采用Cohen's kappa评估两种方法间的一致性。

诊断标准与关键数值

  • CEUS LR-5对HCC的敏感度75.6%、特异度93.8%;CECT/MRI LR-5对HCC的敏感度83.6%、特异度83.3%。
  • CEUS LR-5、LR-4、LR-3中HCC的阳性预测值分别为98.3%、60.0%、25.0%;CECT/MRI相应为95.9%、65.7%、48.1%。
  • CEUS LR-M中非HCC恶性肿瘤的阳性预测值为33.9%,CECT/MRI LR-M为93.3%。
  • CEUS LR-M诊断非HCC恶性肿瘤的敏感度90.9%、特异度84.5%、准确率85.0%;CECT/MRI LR-M分别为63.6%、99.6%、96.7%。

临床应用与阅片要点

  • 作者指出,对于CECT/MRI分类为LR-3和LR-4的结节,应行CEUS检查,至少当结节在常规超声上可检出时。
  • 作者指出,对于CEUS分类为LR-M的结节,有必要通过CECT/MRI重新评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare the classification based on contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) with that of contrast-enhanced CT and MRI (CECT/MRI) LI-RADS for liver nodules in patients at high risk of hepatocellular carcinoma.

METHODS: Two hundred thirty-nine patients with 273 nodules were enrolled in this retrospective study. Each nodule was categorized according to the CEUS LI-RADS version 2017 and CECT/MRI LI-RADS version 2017. The diagnostic performance of CEUS and CECT/MRI was compared. The reference standard was histopathology diagnosis. Inter-modality agreement was assessed with Cohen's kappa.

RESULTS: The inter-modality agreement for CEUS LI-RADS and CECT/MRI LI-RADS was fair with a kappa value of 0.319 (p < 0.001). The positive predictive values (PPVs) of hepatocellular carcinoma (HCC) in LR-5, LR-4, and LR-3 were 98.3%, 60.0%, and 25.0% in CEUS, and 95.9%, 65.7%, and 48.1% in CECT/MRI, respectively. The sensitivities and specificities of LR-5 for diagnosing HCC were 75.6% and 93.8% in CEUS, and 83.6% and 83.3% in CECT/MRI, respectively. The positive predictive values of non-HCC malignancy in CEUS LR-M and CECT/MRI LR-M were 33.9% and 93.3%, respectively. The sensitivity, specificity, and accuracy for diagnosing non-HCC malignancy were 90.9%, 84.5%, and 85.0% in CEUS LR-M and 63.6%, 99.6%, and 96.7% in CECT/MRI LR-M, respectively.

CONCLUSIONS: The inter-modality agreement of the LI-RADS category between CEUS and CECT/MRI is fair. The positive predictive values of HCCs in LR-5 of the CEUS and CECT/MRI LI-RADS are comparable. CECT/MRI LR-M has better diagnostic performance for non-HCC malignancy than CEUS LR-M.

KEY POINTS: • The inter-modality agreement for the final LI-RADS category between CEUS and CECT/MRI is fair. • The LR-5 of CEUS and CECT/MRI LI-RADS corresponds to comparable positive predictive values (PPVs) of HCC. For LR-3 and LR-4 nodules categorized by CECT/MRI, CEUS examination should be performed, at least if they can be detected on plain ultrasound. • CECT/MRI LR-M has better diagnostic performance for non-HCC malignancy than CEUS LR-M. For LR-M nodules categorized by CEUS, re-evaluation by CECT/MRI is necessary.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Ding J, Long L, Zhang X, et al. Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS. Eur Radiol. 2020. PMID: 32803416. doi:10.1007/s00330-020-07159-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。